Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.87 | N/A |
| PEG Ratio (TTM) | -1.46 | N/A |
| P/S Ratio (TTM) | 3.88 | N/A |
| P/B Ratio (TTM) | 0.80 | N/A |
| P/FCF Ratio (TTM) | 3.89 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.87 | N/A |
| Price to 5YR AVG FCF Ratio | 9.93 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.47% | N/A |
| ROE (TTM) | 3.70% | N/A |
| Net Profit Margin (TTM) | 17.72% | N/A |
| ROIC 5YR AVG | 10.80% | N/A |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.28% | 1.92% | -8.66% |
| Revenue | -3.82% | 4.69% | 2.95% |
| Net Income | -5.31% | 7.94% | -2.67% |
| Cash Flow | 321.64% | 5.12% | 19.85% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.94 | N/A |
| Quick Ratio (TTM) | 1.94 | N/A |
| D/E Ratio (TTM) | 0.40 | N/A |
| Interest Coverage (TTM) | 0.23 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.28 | N/A |
| LTL to 5YR AVG FCF | 4.74 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.96% | N/A |